Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Accordi

Cardiovascular Drugs Market Overview, Analysis and Market Growth

Hypertension, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease are some of the most common cardiovascular illnesses. Angina, hypertrophy, and heart failure are all major complications of hypertensive heart disease. High blood pressure in the heart's arteries and muscles promotes narrowing of the arteries, as well as thickening and enlargement of the heart. The global cardiovascular medicine market is primarily driven by increased heart disease prevalence, as well as an ageing population and lifestyle-related disorders. Drugs for the treatment and prevention of cardiovascular disorders are needed to cater to the growing population suffering from these diseases. Another factor projected to drive the global cardiovascular drugs market is an increase in the number of diabetes patients. According to the American Diabetes Association, 30.3 million Americans (9.4% of the total population) had diabetes in 2015.

 

Cardiovascular Drugs Market
Cardiovascular Drugs Market

Increasing R&D activities to launch new products is expected to support in growth of the cardiovascular drugs market

The cardiovascular pharmaceuticals market into five regions: North America, Latin America, Europe, Asia Pacific, Africa, and the Middle East. The global cardiovascular pharmaceuticals market is oligopolistic, with a few companies controlling the majority of the market. Key market players use a variety of techniques to maintain their market position, including new product releases and alliances. For example, in December 2017, Medicure Inc., a Canadian pharmaceutical company, obtained a seven-year exclusive licence to market and sell a cardiovascular drug for the treatment of primary hyperlipidemia or mixed dyslipidemia in the United States and its territories through its subsidiary Medicure International Inc. The US Food and Drug Administration (FDA) approved Sun Pharmaceutical Industries' subsidiary in the United States to sell generic versions of its Coreg CR in October 2017. Coreg CR is a medication that is used to treat a variety of cardiac problems, including high blood pressure and heart failure. Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced their collaboration in August 2017 to develop next-generation therapeutics for the treatment of cardiovascular disorders and heart failure.

Comments

Popular posts from this blog

Global Disposable Face Mask Market Share

Future Prospects of Global Laboratory Proficiency Testing Market

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic